Kairos Pharma Ltd (NYSE:KAPA) saw its stock jump 165% following the announcement of encouraging safety results from its ongoing Phase 2 clinical trial of ENV-105 in patients battling metastatic ...

A Flinders University study shows that bowel cancer survivors face an elevated risk of developing multiple primary cancers ...

Investing.com -- Kairos Pharma Ltd (NYSE: KAPA) stock surged 165% after the clinical-stage biopharmaceutical company reported positive safety results from its ongoing Phase 2 clinical trial of ENV-105 ...

Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces positive safety results from its ongoing Phase 2 ...

Former Sky News presenter Dermot Murnaghan has said he “fell through the gaps” and had a “wake-up call” after receiving his ...

Stage four prostate cancer can mean that the cancer has spread into different parts of the body including nearby body organs, ...

Although an elevated PSA measurement can indicate prostate cancer, there can be other reasons for elevated levels.

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of these men will die of causes ...

Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.

During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...

ArteraAI Prostate analyzes digital pathology images of a prostate cancer biopsy slide to help clinicians predict long-term outcomes.

Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...